Benign Prostatic Hyperplasia Treatment Market Report 2026
Download Free Sample Buy Now
Benign Prostatic Hyperplasia Treatment Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Benign Prostatic Hyperplasia Treatment Market Report 2026

Global Outlook – By Treatment (Minimal Invasive Surgery, Invasive Surgery), By Therapeutic Class (Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes), By End User (Home Healthcare, Hospitals And Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Benign Prostatic Hyperplasia Treatment Market Overview

• Benign Prostatic Hyperplasia Treatment market size has reached to $8.69 billion in 2025

• Expected to grow to $11.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: Rising Adoption Of Minimally Invasive Surgeries Driving Growth In BPH Treatment

• Market Trend: Minimally Invasive Drug-Eluting Therapies Transforming Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Benign Prostatic Hyperplasia Treatment Market?

Benign prostatic hyperplasia (BPH) treatment refers to medical, minimally invasive, and surgical approaches used to manage the symptoms of an enlarged prostate. BPH is a common condition in aging men, leading to urinary issues such as frequent urination, weak stream, and incomplete bladder emptying.

The main treatments of benign prostatic hyperplasia (BPH) include minimally invasive surgery (MIS) and invasive surgery. Minimally Invasive Surgery (MIS) refers to surgical techniques that use small incisions, specialized instruments, and advanced imaging technology to perform procedures with minimal trauma to the body. The therapeutic classes for BPH treatment include alpha blockers, 5-alpha reductase inhibitors, phosphodiesterase-5 inhibitors, and other therapeutic classes. These treatments cater to various end users, including home healthcare, hospitals and clinics, as well as research and manufacturing facilities.

Benign Prostatic Hyperplasia Treatment Market Global Report 2026 Market Report bar graph

What Is The Benign Prostatic Hyperplasia Treatment Market Size and Share 2026?

The benign prostatic hyperplasia treatment market size has grown strongly in recent years. It will grow from $8.69 billion in 2025 to $9.17 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing aging male population, rising prevalence of urinary disorders, expansion of urology specialty services, growing use of pharmacological treatments, improved access to diagnostic screening.

What Is The Benign Prostatic Hyperplasia Treatment Market Growth Forecast?

The benign prostatic hyperplasia treatment market size is expected to see strong growth in the next few years. It will grow to $11.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of robotic-assisted prostate procedures, rising focus on personalized treatment planning, expansion of home-based therapy options, growing integration of digital patient monitoring tools, increasing demand for minimally invasive interventions. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising demand for targeted drug therapies, growing use of combination treatment approaches, expansion of outpatient treatment settings, enhanced focus on symptom management and quality of life.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Benign Prostatic Hyperplasia Treatment Market Segmentation

1) By Treatment: Minimal Invasive Surgery, Invasive Surgery

2) By Therapeutic Class: Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes

3) By End User: Home Healthcare, Hospitals And Clinics

Subsegments:

1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP), Laser Surgery, Prostatic Urethral Lift, Transurethral Incision of the Prostate (TUIP), Microwave Therapy

2) By Invasive Surgery: Open Prostatectomy, Robotic Prostatectomy

What Is The Driver Of The Benign Prostatic Hyperplasia Treatment Market?

The rise in adoption of minimally invasive surgeries is expected to propel the growth of the benign prostatic hyperplasia treatment market going forward. Minimally invasive surgeries are procedures that involve small incisions or no incisions at all, using specialized instruments to reduce recovery time, pain, and risk of complications. The rise in adoption of minimally invasive surgeries is driven by benefits such as shorter recovery times, reduced pain, lower risk of complications, and improved cosmetic outcomes. Benign prostatic hyperplasia treatment through minimally invasive surgeries provides patients with reduced recovery times, lower risks of complications, and effective symptom relief, enhancing overall surgical outcomes. For instance, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a U.S.-based professional association, there were nearly 25.4 million minimally invasive cosmetic procedures performed in 2023, up 7% from 23.7 million in 2022. Therefore, the rise in adoption of minimally invasive surgeries is driving the growth of the benign prostatic hyperplasia treatment industry.

Key Players In The Global Benign Prostatic Hyperplasia Treatment Market

Major companies operating in the benign prostatic hyperplasia treatment market are Astellas Pharma Inc., Bayer AG, Pfizer Inc., Merck & Co Inc., Eli Lilly and Company, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sanofi S.A., Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical Incorporated, Coloplast Group, Medtronic Public Limited Company, Urovant Sciences Ltd., UroGen Pharma Ltd., Urologix Inc., Zenflow Inc., HistoSonics Inc.

Global Benign Prostatic Hyperplasia Treatment Market Trends and Insights

Major companies operating in the benign prostatic hyperplasia treatment market are focusing on the development of innovative solutions, such as intraprostatic drug elution therapy, to gain a competitive advantage. Intraprostatic drug elution therapy involves placing a bioabsorbable implant directly into the prostate to locally deliver a therapeutic agent over time. For instance, in May 2025, Resurge Therapeutics, a US-based urology technology developer, introduced a paclitaxel-eluting bioabsorbable implant for BPH; it offers office-based deployment, targeted drug release, and minimal pain post-procedure. This localized delivery reduces systemic exposure, enhances efficacy, and preserves sexual function. However, long-term safety and large-scale adoption remain under evaluation.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Market?

In October 2023, Laborie Medical Technologies, Inc., a US-based medical technology company, acquired Urotronic for $600 million. With this acquisition, Laborie Medical Technologies aims to expand its interventional urology portfolio, enhance its technological capabilities, and strengthen its global market position in minimally invasive urological treatments. Urotronic, Inc. is a US-based medical device company that specifically develops and markets a minimally invasive treatment for benign prostatic hyperplasia (BPH).

Regional Outlook

North America was the largest region in the benign prostatic hyperplasia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Benign Prostatic Hyperplasia Treatment Market?

The benign prostatic hyperplasia treatment market consists of revenues earned by entities by providing services such as pharmacological treatments, minimally invasive procedures, surgical treatments, diagnostic services, and prostatic stents. The market value includes the value of related goods sold by the service provider or included within the service offering. The benign prostatic hyperplasia treatment market also includes sales of transurethral microwave thermotherapy, prostatic urethral lift, acupuncture, combination therapy, phosphodiesterase-5 inhibitors, and minimally invasive devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Benign Prostatic Hyperplasia Treatment Market Report 2026?

The benign prostatic hyperplasia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the benign prostatic hyperplasia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Benign Prostatic Hyperplasia Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $9.17 billion
Revenue Forecast In 2035 $11.29 billion
Growth Rate CAGR of 5.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Therapeutic Class, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Astellas Pharma Inc., Bayer AG, Pfizer Inc., Merck & Co Inc., Eli Lilly and Company, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sanofi S.A., Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical Incorporated, Coloplast Group, Medtronic Public Limited Company, Urovant Sciences Ltd., UroGen Pharma Ltd., Urologix Inc., Zenflow Inc., HistoSonics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Benign Prostatic Hyperplasia Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Benign Prostatic Hyperplasia Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Benign Prostatic Hyperplasia Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Benign Prostatic Hyperplasia Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Minimally Invasive Surgical Techniques

4.2.2 Rising Demand For Targeted Drug Therapies

4.2.3 Growing Use Of Combination Treatment Approaches

4.2.4 Expansion Of Outpatient Treatment Settings

4.2.5 Enhanced Focus On Symptom Management And Quality Of Life

5. Benign Prostatic Hyperplasia Treatment Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Urology Centers

5.3 Home Healthcare Providers

5.4 Surgical Centers

5.5 Research And Manufacturing Facilities

6. Benign Prostatic Hyperplasia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Benign Prostatic Hyperplasia Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Benign Prostatic Hyperplasia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Benign Prostatic Hyperplasia Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Benign Prostatic Hyperplasia Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Benign Prostatic Hyperplasia Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Benign Prostatic Hyperplasia Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Benign Prostatic Hyperplasia Treatment Market Segmentation

9.1. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Minimal Invasive Surgery, Invasive Surgery

9.2. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes

9.3. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Home Healthcare, Hospitals And Clinics

9.4. Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Transurethral Resection of the Prostate (TURP), Laser Surgery, Prostatic Urethral Lift, Transurethral Incision of the Prostate (TUIP), Microwave Therapy

9.5. Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Open Prostatectomy, Robotic Prostatectomy

10. Benign Prostatic Hyperplasia Treatment Market Regional And Country Analysis

10.1. Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market

11.1. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Benign Prostatic Hyperplasia Treatment Market

12.1. China Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Benign Prostatic Hyperplasia Treatment Market

13.1. India Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Benign Prostatic Hyperplasia Treatment Market

14.1. Japan Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Benign Prostatic Hyperplasia Treatment Market

15.1. Australia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Benign Prostatic Hyperplasia Treatment Market

16.1. Indonesia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Benign Prostatic Hyperplasia Treatment Market

17.1. South Korea Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Benign Prostatic Hyperplasia Treatment Market

18.1. Taiwan Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Benign Prostatic Hyperplasia Treatment Market

19.1. South East Asia Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Benign Prostatic Hyperplasia Treatment Market

20.1. Western Europe Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Benign Prostatic Hyperplasia Treatment Market

21.1. UK Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Benign Prostatic Hyperplasia Treatment Market

22.1. Germany Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Benign Prostatic Hyperplasia Treatment Market

23.1. France Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Benign Prostatic Hyperplasia Treatment Market

24.1. Italy Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Benign Prostatic Hyperplasia Treatment Market

25.1. Spain Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Benign Prostatic Hyperplasia Treatment Market

26.1. Eastern Europe Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Benign Prostatic Hyperplasia Treatment Market

27.1. Russia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Benign Prostatic Hyperplasia Treatment Market

28.1. North America Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Benign Prostatic Hyperplasia Treatment Market

29.1. USA Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Benign Prostatic Hyperplasia Treatment Market

30.1. Canada Benign Prostatic Hyperplasia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Benign Prostatic Hyperplasia Treatment Market

31.1. South America Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Benign Prostatic Hyperplasia Treatment Market

32.1. Brazil Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Benign Prostatic Hyperplasia Treatment Market

33.1. Middle East Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Benign Prostatic Hyperplasia Treatment Market

34.1. Africa Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Segmentation By Therapeutic Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Benign Prostatic Hyperplasia Treatment Market Regulatory and Investment Landscape

36. Benign Prostatic Hyperplasia Treatment Market Competitive Landscape And Company Profiles

36.1. Benign Prostatic Hyperplasia Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Benign Prostatic Hyperplasia Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Benign Prostatic Hyperplasia Treatment Market Company Profiles

36.3.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Benign Prostatic Hyperplasia Treatment Market Other Major And Innovative Companies

AbbVie Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sanofi S.A., Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical Incorporated, Coloplast Group, Medtronic Public Limited Company, Urovant Sciences Ltd., UroGen Pharma Ltd., Urologix Inc., Zenflow Inc., HistoSonics Inc.

38. Global Benign Prostatic Hyperplasia Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Market

40. Benign Prostatic Hyperplasia Treatment Market High Potential Countries, Segments and Strategies

40.1 Benign Prostatic Hyperplasia Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Benign Prostatic Hyperplasia Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Benign Prostatic Hyperplasia Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Benign Prostatic Hyperplasia Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Benign Prostatic Hyperplasia Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Benign Prostatic Hyperplasia Treatment Market, Supply Chain Analysis
  • Table 4: Global Benign Prostatic Hyperplasia Treatment Market, Major Raw Material Providers
  • Table 5: Global Benign Prostatic Hyperplasia Treatment Market, Major Resource Providers
  • Table 6: Global Benign Prostatic Hyperplasia Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Benign Prostatic Hyperplasia Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Benign Prostatic Hyperplasia Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Benign Prostatic Hyperplasia Treatment Market, Major Trends
  • Table 10: Global Benign Prostatic Hyperplasia Treatment Market, Major End Users
  • Table 11: Global Benign Prostatic Hyperplasia Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Benign Prostatic Hyperplasia Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Benign Prostatic Hyperplasia Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Benign Prostatic Hyperplasia Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Benign Prostatic Hyperplasia Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Benign Prostatic Hyperplasia Treatment Market - Company Scoring Matrix
  • Table 96: Astellas Pharma Inc. Financial Performance
  • Table 97: Bayer AG Financial Performance
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: Merck & Co Inc. Financial Performance
  • Table 100: Eli Lilly and Company Financial Performance
  • Table 101: Global Benign Prostatic Hyperplasia Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Benign Prostatic Hyperplasia Treatment Market, Competitive Dashboard
  • Table 103: Global Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 105: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By Therapeutic Class, 2025 – 2030
  • Table 106: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Benign Prostatic Hyperplasia Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Benign Prostatic Hyperplasia Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Benign Prostatic Hyperplasia Treatment Market, Supply Chain Analysis
  • Figure 4: Global Benign Prostatic Hyperplasia Treatment Market, Major Raw Material Providers
  • Figure 5: Global Benign Prostatic Hyperplasia Treatment Market, Major Resource Providers
  • Figure 6: Global Benign Prostatic Hyperplasia Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Benign Prostatic Hyperplasia Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Benign Prostatic Hyperplasia Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Benign Prostatic Hyperplasia Treatment Market, Major Trends
  • Figure 10: Global Benign Prostatic Hyperplasia Treatment Market, Major End Users
  • Figure 11: Global Benign Prostatic Hyperplasia Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Benign Prostatic Hyperplasia Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Benign Prostatic Hyperplasia Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Benign Prostatic Hyperplasia Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Benign Prostatic Hyperplasia Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Benign Prostatic Hyperplasia Treatment Market - Company Scoring Matrix
  • Figure 96: Astellas Pharma Inc. Financial Performance
  • Figure 97: Bayer AG Financial Performance
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: Merck & Co Inc. Financial Performance
  • Figure 100: Eli Lilly and Company Financial Performance
  • Figure 101: Global Benign Prostatic Hyperplasia Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Benign Prostatic Hyperplasia Treatment Market, Competitive Dashboard
  • Figure 103: Global Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 105: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By Therapeutic Class, 2025 – 2030
  • Figure 106: Global, Benign Prostatic Hyperplasia Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Outlook for Infection Control Surveillance Solutions Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Infection Control Surveillance Solutions Market: Key Developments and Future Strategies to 2029

Global Insights: Inpatient Services Market Expected to Surpass $2,326.38 Billion by 2029

Read More About Global Insights: Inpatient Services Market Expected to Surpass $2,326.38 Billion by 2029

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Read More About Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Read More About Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2026 - Global Outlook – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedur...

Drugs For Benign Prostatic hypertrophy Market Report 2026 - Global Outlook – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types ), By Distribution Channel (Hospital Pharmacies...

Prostate Cancer Drugs Market Report 2026 - Global Outlook – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer ), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy ),...

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026 - Global Outlook – By Type (Single Photon Emission Computed Tomography (SPECT), Photon Emission Computed Tomography (PET)), By Test Type (Preliminary Tests,...

Prostate Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell ...

Urothelial Carcinoma Treatment Market Report 2026 - Global Outlook – By Type (Non-Invasive Urothelial Carcinoma Treatment, Invasive Urothelial Carcinoma Treatment), By Treatment (Immunotherapy, Radiotherapy, Chemotherapy...

Overactive Bladder Treatment Market Report 2026 - Global Outlook – By Disease Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), By Therapy (Anticholinergics, Mirabegron, Neurostimulation, Intravesi...

Pediatric Bladder Treatment Market Report 2026 - Global Outlook – By Type (Diurnal Incontinence, Enuresis, Other Types), By Treatment (Urotherapy, Medication, Surgical Reconstruction, Other Treatments), By Route Of Admin...

Frequently Asked Questions

The Benign Prostatic Hyperplasia Treatment market was valued at $8.69 billion in 2025, increased to $9.17 billion in 2026, and is projected to reach $11.29 billion by 2030.

The global Benign Prostatic Hyperplasia Treatment market is expected to grow at a CAGR of 5.3% from 2026 to 2035 to reach $11.29 billion by 2035.

Some Key Players in the Benign Prostatic Hyperplasia Treatment market Include, Astellas Pharma Inc., Bayer AG, Pfizer Inc., Merck & Co Inc., Eli Lilly and Company, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sanofi S.A., Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical Incorporated, Coloplast Group, Medtronic Public Limited Company, Urovant Sciences Ltd., UroGen Pharma Ltd., Urologix Inc., Zenflow Inc., HistoSonics Inc. .

Major trend in this market includes: Minimally Invasive Drug-Eluting Therapies Transforming Treatment. For further insights on this market. request a sample here

North America was the largest region in the benign prostatic hyperplasia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benign prostatic hyperplasia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us